接受托非格列净治疗的2型糖尿病患者血清中肝脏相关指标、尿酸和血红蛋白水平的变化--UTOPIA研究的事后分析

{"title":"接受托非格列净治疗的2型糖尿病患者血清中肝脏相关指标、尿酸和血红蛋白水平的变化--UTOPIA研究的事后分析","authors":"N. Katakami, T. Mita, Yasunori Sato, H. Watada, Iichiro Shimomura","doi":"10.1007/s13340-024-00693-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":503823,"journal":{"name":"Diabetology International","volume":"116 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Changes in serum levels of liver-related parameters, uric acid, and hemoglobin in patients with type 2 diabetes mellitus under treatment with tofogliflozin—a post-hoc analysis of the UTOPIA study\",\"authors\":\"N. Katakami, T. Mita, Yasunori Sato, H. Watada, Iichiro Shimomura\",\"doi\":\"10.1007/s13340-024-00693-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":503823,\"journal\":{\"name\":\"Diabetology International\",\"volume\":\"116 5\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-02-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Diabetology International\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s13340-024-00693-x\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s13340-024-00693-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}